Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation

Published:2009-04 Issue:4 Volume:15 Page:416-420
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Lee Stephanie J.,Seaborn Travis,Mao Frances J.,Massey Susan C.,Luu Ngoc Q.,Schubert Mary A.,Chien Jason W.,Carpenter Paul A.,Moravec Carina,Martin Paul J.,Flowers Mary E.D.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study;Stern;Biol Blood Marrow Transplant,2001

2. Nonmalignant late effects after allogeneic stem cell transplantation;Socie;Blood,2003

3. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study;Baker;Blood,2004

4. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation;Savani;Biol Blood Marrow Transplant,2006

5. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study;Fraser;Blood,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes Mellitus in HSCT;Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation;2024

2. Metabolic Disease Incidence After Allogeneic Stem Cell Transplantation: A Nationwide Korean Case-Control Study;The Journal of Clinical Endocrinology & Metabolism;2021-12-14

3. The skeletal stem cell;Marcus and Feldman's Osteoporosis;2021

4. Proceedings From the Global Cardio-Oncology Summit;JACC: CardioOncology;2019-12

5. Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data;Journal of Clinical Lipidology;2018-03